Kallikrein 4 抗体 (AA 242-254)
Quick Overview for Kallikrein 4 抗体 (AA 242-254) (ABIN636259)
抗原
See all Kallikrein 4 (KLK4) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 242-254
-
纯化方法
- Affinity chromatography purified
-
免疫原
- KLK-L1 antibody was raised in rabbit using AA 242-254 [KFTEWIEKTVQAS] of the human 39 kDa KLK-L1 (KLK4) protein as the immunogen.
-
亚型
- IgG
-
-
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 32-256) antibody
KLK4 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 32-255) antibodyKLK4 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 159-254) antibodyKLK4 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2A4 unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 30-254) antibodyKLK4 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 31-254) antibodyKLK4 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 27-254) antibodyKLK4 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein-Related Peptidase 4 (KLK4) (AA 85-115) antibodyKLK4 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal RB6105 unconjugated
-
-
应用备注
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
限制
- 仅限研究用
-
-
-
浓度
- Lot specific
-
缓冲液
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- Kallikrein 4 (KLK4) (Kallikrein-Related Peptidase 4 (KLK4))
-
别名
- KLK-L1
-
背景
- Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. A novel Kallikrein gene Prostase/KLK-L1 (also known as KLK4) is expressed and is up-regulated by androgens and progestins. KLK-L1 may be involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.
-
途径
- Complement System
抗原
-
